Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
1997 1
2001 1
2002 1
2003 1
2010 1
2011 1
2013 1
2014 1
2015 1
2017 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Role of surgery in localized initially unresectable neuroblastoma.
Ahmed G, Fawzy M, Elmenawi S, Elzomor H, Yosif Y, Elkinaai N, Refaat A, Hegazy M, El Shafiey M. Ahmed G, et al. J Pediatr Urol. 2018 Jun;14(3):231-236. doi: 10.1016/j.jpurol.2018.03.008. Epub 2018 Mar 31. J Pediatr Urol. 2018. PMID: 29636298 Review.
PURPOSE: Evaluating the role of surgery and the extent of tumor resection on the outcome of patients with localized initially unresectable neuroblastoma (NB). PATIENTS AND METHODS: This was a retrospective case review study including patients with localized initiall …
PURPOSE: Evaluating the role of surgery and the extent of tumor resection on the outcome of patients with localized initially unresectabl …
Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy.
Rubie H, Coze C, Plantaz D, Munzer C, Defachelles AS, Bergeron C, Thomas C, Chastagner P, Valteau-Couanet D, Michon J, Mosseri V, Hartmann O; Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique. Rubie H, et al. Br J Cancer. 2003 Nov 3;89(9):1605-9. doi: 10.1038/sj.bjc.6601259. Br J Cancer. 2003. PMID: 14583756 Free PMC article.
The purpose of this study was to evaluate the efficacy of low-dose chemotherapy in infants with localised and unresectable neuroblastoma (NB). All consecutive infants with localised NB and no N-myc amplification were eligible in the SFOP-NBL 94 study. ...
The purpose of this study was to evaluate the efficacy of low-dose chemotherapy in infants with localised and unresectable neurobl …
Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for Neuroblastoma.
Garaventa A, De Bernardi B, Pianca C, Donfrancesco A, Cordero di Montezemolo L, Di Tullio MT, Bagnulo S, Mancini A, Carli M, Pession A, Arrighini A, Di Cataldo A, Tamaro P, Iasonni V, Taccone A, Rogers D, Boni L; Italian Cooperative Group dor Neuroblastoma. Garaventa A, et al. J Clin Oncol. 1993 Sep;11(9):1770-9. doi: 10.1200/JCO.1993.11.9.1770. J Clin Oncol. 1993. PMID: 8355044
PURPOSE: To define factors that influence outcome in children with localized but unresectable neuroblastoma by retrospective investigation of response to therapy and outcome in 21 Italian institutions. ...Outcome of this last group improved with the HD protocol (PFS …
PURPOSE: To define factors that influence outcome in children with localized but unresectable neuroblastoma by retrospective i …
Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes.
Avanzini S, Pio L, Erminio G, Granata C, Holmes K, Gambart M, Buffa P, Castel V, Valteau Couanet D, Garaventa A, Pistorio A, Cecchetto G, Martucciello G, Mattioli G, Sarnacki S. Avanzini S, et al. Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26605. Epub 2017 Apr 25. Pediatr Blood Cancer. 2017. PMID: 28440012
PURPOSE: To evaluate the impact of image-defined risk factor (IDRF) modification after chemotherapy on surgical outcomes, event-free survival (EFS), and overall survival (OS) among patients enrolled in the European Unresectable Neuroblastoma (EUNB) study. METHODS: I …
PURPOSE: To evaluate the impact of image-defined risk factor (IDRF) modification after chemotherapy on surgical outcomes, event-free surviva …
Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1.
Rubie H, De Bernardi B, Gerrard M, Canete A, Ladenstein R, Couturier J, Ambros P, Munzer C, Pearson AD, Garaventa A, Brock P, Castel V, Valteau-Couanet D, Holmes K, Di Cataldo A, Brichard B, Mosseri V, Marquez C, Plantaz D, Boni L, Michon J. Rubie H, et al. J Clin Oncol. 2011 Feb 1;29(4):449-55. doi: 10.1200/JCO.2010.29.5196. Epub 2010 Dec 20. J Clin Oncol. 2011. PMID: 21172879 Clinical Trial.
PURPOSE: To evaluate the efficacy of low-dose chemotherapy in infants with nonmetastatic and unresectable neuroblastoma (NB) without MYCN amplification. PATIENTS AND METHODS: Infants with localized NB and no MYCN amplification were eligible in the SIOPEN Infant Neur …
PURPOSE: To evaluate the efficacy of low-dose chemotherapy in infants with nonmetastatic and unresectable neuroblastoma (NB) w …
Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Societe Francaise d'Oncologie Pediatrique.
Rubie H, Plantaz D, Coze C, Michon J, Frappaz D, Baranzelli MC, Chastagner P, Peyroulet MC, Hartmann O; Neuroblastoma Study Group, Société Française d'Oncologie Pédiatrique. Rubie H, et al. Med Pediatr Oncol. 2001 Jan;36(1):247-50. doi: 10.1002/1096-911X(20010101)36:1<247::AID-MPO1061>3.0.CO;2-Z. Med Pediatr Oncol. 2001. PMID: 11464897
Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors.
Garaventa A, Boni L, Lo Piccolo MS, Tonini GP, Gambini C, Mancini A, Tonegatti L, Carli M, di Montezemolo LC, Di Cataldo A, Casale F, Mazzocco K, Cecchetto G, Rizzo A, Bernardi B; Italian Cooperative Group for Neuroblastoma. Garaventa A, et al. Ann Oncol. 2002 Jun;13(6):956-64. doi: 10.1093/annonc/mdf165. Ann Oncol. 2002. PMID: 12123342 Free article.
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study.
Kohler JA, Rubie H, Castel V, Beiske K, Holmes K, Gambini C, Casale F, Munzer C, Erminio G, Parodi S, Navarro S, Marquez C, Peuchmaur M, Cullinane C, Brock P, Valteau-Couanet D, Garaventa A, Haupt R. Kohler JA, et al. Eur J Cancer. 2013 Nov;49(17):3671-9. doi: 10.1016/j.ejca.2013.07.002. Epub 2013 Jul 29. Eur J Cancer. 2013. PMID: 23907002 Clinical Trial.
BACKGROUND: In children older than 1 year with localised unresectable neuroblastoma (NB), treatment strategies are heterogeneous according to the national groups. ...
BACKGROUND: In children older than 1 year with localised unresectable neuroblastoma (NB), treatment strategies are heterogeneo …
Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).
Rubie H, Delattre O, Hartmann O, Combaret V, Michon J, Bénard J, Peyroulet MC, Plantaz D, Coze C, Chastagner P, Baranzelli MC, Frappaz D, Lemerle J, Sommelet D. Rubie H, et al. Eur J Cancer. 1997 Oct;33(12):1917-22. doi: 10.1016/s0959-8049(97)00295-5. Eur J Cancer. 1997. PMID: 9516824
In addition to the assessment of a new chemotherapy regimen in unresectable neuroblastoma, we evaluated the prognostic significance of MYCN amplification and loss of the short arm of chromosome 1 (LOH1p). ...
In addition to the assessment of a new chemotherapy regimen in unresectable neuroblastoma, we evaluated the prognostic signifi …
11 results